Bausch Health
BHC
#4088
Rank
NZ$5.50 B
Marketcap
NZ$14.71
Share price
-1.96%
Change (1 day)
29.32%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

EPS for Bausch Health (BHC)

EPS in 2023 (TTM): NZ-$4.29

According to Bausch Health 's latest financial reports the company's current EPS (TTM) is NZ-$4.05. In 2022 the company made an earnings per share (EPS) of NZ-$1.11 an increase over its 2021 EPS that were of NZ-$4.75.

EPS history for Bausch Health from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)NZ-$4.29286.8%
2022NZ-$1.11-76.64%
2021NZ-$4.7568.45%
2020NZ-$2.82-68.91%
2019NZ-$9.06-57.11%
2018NZ-$21.14-272.22%
2017NZ$12.27-199.29%
2016NZ-$12.36798.7%
2015NZ-$1.38-128.31%
2014NZ$4.86-204.62%
2013NZ-$4.64602.7%
2012NZ-$0.66-171.15%
2011NZ$0.93-143.96%
2010NZ-$2.11-206.57%
2009NZ$1.98-11.2%
2008NZ$2.232.46%
2007NZ$2.18-7.58%
2006NZ$2.36-14.29%
2005NZ$2.7554%
2004NZ$1.79-500%
2003NZ-$0.45-141.67%
2002NZ$1.07-4.76%
2001NZ$1.13-175%
2000NZ-$1.50-268%
1999NZ$0.8914.94%
1998NZ$0.7820.83%
1997NZ$0.6453.83%
1996NZ$0.42

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
NZ-$0.16-96.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
NZ-$1.70-58.15%๐Ÿ‡บ๐Ÿ‡ธ USA